# Fluid Resuscitation in Early Septic Shock

> **NCT00819416** · PHASE2 · COMPLETED · sponsor: **Ottawa Hospital Research Institute** · enrollment: 47 (actual)

## Conditions studied

- Septic Shock
- Sepsis
- Severe Sepsis

## Interventions

- **DRUG:** 5% albumin
- **DRUG:** Normal Saline

## Key facts

- **NCT ID:** NCT00819416
- **Lead sponsor:** Ottawa Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2009-10
- **Final completion:** 2010-02
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2010-04-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00819416

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00819416, "Fluid Resuscitation in Early Septic Shock". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00819416. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*